Ash Boutros at Cardiometabolic Biopharma LeaderSpeaker
Profile
Ashraf (Ash) Boutros is a biopharma commercial leader with more than 20 years of experience across finance and global pharmaceutical strategy. He has led brand strategy and launch readiness for innovative therapies in cardiometabolic disease, driving cross-functional alignment across R&D, Medical Affairs, Regulatory, and Sales to accelerate adoption and optimize lifecycle performance. Ash has contributed to enterprise-level obesity and diabetes strategy, helping elevate obesity as a core business priority in a rapidly evolving market. A licensed CPA in the U.S. and Canada, he brings a distinctive combination of financial discipline and commercial leadership to advancing sustainable growth and meaningful healthcare innovation.
Agenda Sessions
What’s Next in Direct-to-Patient: Optimizing for Access, Affordability & Adherence
, 10:00amView Session
